Company / Net Debt per Share
Veracyte, Inc. Net Debt per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$2.98
FY2021
5-year range
-$2.98 / -$2.98
FY2017-FY2021
Trend
+57.6%
vs FY2020
Sector context
#86 of 100
Health Care
What the data says
Veracyte, Inc.'s net debt per share of $-2.98 is lower than 86% of companies in the Health Care sector (FY2021). Net Debt per Share returned to growth in FY2021 after 3 years of decline, reaching $-2.98.
Based on SEC 10-K filings.
-2.98 in FY2021.
Increased from $-3.88 to $-2.98 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 100This company -$2.98 Sector average $7.63
▼
-139.0% below sector average
Key checks
Key Insights
- In FY2021, net debt per share increased 57.6% year-over-year.
- Ranks #86 out of 100 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2017.
- Lowest net debt per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$2.98 | +57.6% |
| FY2020 | -$7.02 | -80.9% |
| FY2019 | -$3.88 | -142.4% |
| FY2018 | -$1.60 | -503.9% |
| FY2017 | -$0.27 | +78.6% |
| FY2016 | -$1.24 | +18.2% |
As of FY2021 · SEC 10-K · Updated Feb 28, 2026